Drugs & Targets EMA accepts tucatinib application in HER2-positive breast cancer February 07, 2020Vol.46 No.06
Drugs & Targets EMA accepts application for belantamab mafodotin for multiple myeloma February 07, 2020Vol.46 No.06
Drugs & Targets European advisory group backs Pfizer’s Rituxan biosimilar February 07, 2020Vol.46 No.06
Drugs & Targets FDA, FTC collaborate to deter anti-competitive practices involving biosimilars February 07, 2020Vol.46 No.06
Clinical Roundup Lung cancer screening decision aid through tobacco quitlines improves informed decision-making February 07, 2020Vol.46 No.06
Clinical Roundup Study: liquid biopsy is an effective predictor of stage III melanoma relapse February 07, 2020Vol.46 No.06
Clinical Roundup First-ever single-cell analysis of uveal melanoma reported February 07, 2020Vol.46 No.06
In Brief Satish Gopal named director of the NCI Center for Global Health February 07, 2020Vol.46 No.06
